Luminor Medical Technologies featured on CFN Media

Luminor Medical Technologies (TSXV:LMT) recently got featured on CFN Media regarding the company’s partnership with Constance Therapeutics. 

The companies have agreed to develop and market cannabis-based sexual health products, a large and growing market, starting this year in California.

The article describes the California Cannabis market as an extremely profitable one with revenue that is projected to reach $3.7 billion in 2018 and rise to $5.1 billion in 2019. The U.S. sexual wellness market alone is projected to reach $8.8 billion by 2025.

“Constance Therapeutics represents an evidence-based process. Her company has been focused on producing scientifically derived cannabis products for the past 10 years — everything that goes through her process is completely vetted. The botanicals that are used are not haphazard; they’ve actually been tested for efficacy and for their ability to work well with cannabis components,” stated the Luminor Science CEO Anton Mattadeen on their recent partnership.

To see the full article, click here.

Click here to connect with Luminor Medical Technologies (TSXV:LMT) for an Investor Presentation

Source: www.cannabisfn.com